Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 10-08-2018, 02:52 PM #1
eds195 eds195 is offline
Member
 
Join Date: Feb 2015
Location: NJ
Posts: 153
8 yr Member
eds195 eds195 is offline
Member
 
Join Date: Feb 2015
Location: NJ
Posts: 153
8 yr Member
Default Sunovion Expects APL-130277 Will Ably Treat Off Episodes, Awaits FDA Decision

Sunovion Expects APL-130277 Will Ably Treat Off Episodes, Awaits FDA Decision

Potential Parkinson's Treatment for Off Periods Shows 'Key Benefit' of Working Well, Sunovion Says
eds195 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
johnt (10-08-2018), KNPV (10-08-2018), soccertese (10-09-2018)

advertisement
Old 10-08-2018, 04:11 PM #2
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
Default

APL-130277 (Sunovion) is a sublingual version of apomorphine, a dopamine agonist. As such, it offers a more convenient delivery than present versions of apomorphine, which need to be injected (e.g. Apokyn).

Its purpose is supposed to be dealing with "off" periods. It is suitable for this because it reaches maximum concentration in about 20 minutes, as compared to the 60 minutes of levodopa/carbidopa.

Apomorphine's weakness is that it has a short half-life, 30 minutes as compared to the 90 minutes of L/C. So unless you take other medication you will go "off" quickly.

I think most people will benefit more by having their present drug regimen optimised; making use of the longer half-life of other drugs to give a smoother control of the symptoms.

There is a role for this drug in the case of unexpected "offs", but one has to be careful. Suppose you take a dose of L/C, which has its impact delayed by something in the diet. You go "off" and take the apomorphine, just before the L/C dose kicks in.

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
eds195 (10-11-2018), jeffreyn (10-08-2018)
Old 10-09-2018, 11:23 AM #3
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
Default

Quote:
Originally Posted by johnt View Post
APL-130277 (Sunovion) is a sublingual version of apomorphine, a dopamine agonist. As such, it offers a more convenient delivery than present versions of apomorphine, which need to be injected (e.g. Apokyn).

Its purpose is supposed to be dealing with "off" periods. It is suitable for this because it reaches maximum concentration in about 20 minutes, as compared to the 60 minutes of levodopa/carbidopa.

Apomorphine's weakness is that it has a short half-life, 30 minutes as compared to the 90 minutes of L/C. So unless you take other medication you will go "off" quickly.

I think most people will benefit more by having their present drug regimen optimised; making use of the longer half-life of other drugs to give a smoother control of the symptoms.

There is a role for this drug in the case of unexpected "offs", but one has to be careful. Suppose you take a dose of L/C, which has its impact delayed by something in the diet. You go "off" and take the apomorphine, just before the L/C dose kicks in.

John

i have a different opinion, i think there is a need for a "rescue" drug to get you back on in 20minutes or so. there are some people that can't tolerate longer lasting agonists and can't afford rytary so have to struggle with C/L and C/L extenders like entacapone and have to deal with the results of eating too much protein if they loose their self control and overindulge in protein. if i do that, i have to wait up to 2hrs before taking C/L. i will take an extra 100mg if C/L when i know i've eaten too much protein but i risk having my BP going too low. if this form of apomorphine lets you splurge on protein once in awhile - assuming it isn't greatly affected by protein - then for me it fills a valuable need. i recently added MIRAPEX, didn't like it but toughed it out to reach 3mg/day and had to stop, started seeing / hearing things that weren't there. couldn't tolerate amantadine, entacapone added maybe 45minutes at the best, i have high blood pressure so can't take a mao-b inhibitor so not that easy to adjust my drug regime, especially since i am taking enough C/L that i risk my BP going too low. so a convienent quick acting apomorphine would be a godsend for me if it significantly reduces the inevitable OFF time if i happen to eat more than 4 grams of protein which i do once a day.
soccertese is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
jeffreyn (10-09-2018)
Old 10-11-2018, 10:32 AM #4
eds195 eds195 is offline
Member
 
Join Date: Feb 2015
Location: NJ
Posts: 153
8 yr Member
eds195 eds195 is offline
Member
 
Join Date: Feb 2015
Location: NJ
Posts: 153
8 yr Member
Default

I have the same issue witha 2-3 hour wait after eating protein and sometimes that dose never kicks in, rare but it happens. This article says one layer contains an acid neutralizer "thought to improve absorption," that doesn't seem like a guarantee to me. When I started reading this article, I thought I was reading about the inhaled version of the rescue drug which I have been excited about. That one I feel sure would bypass the digestive process. My neuro told me a while back that he thought 5-10 minutes for the inhaled version to take effect. This is the last I have seen about Acorda and its inhaled version:Inhaled Levodopa for 'Off' Time Moves to FDA Review. UPDATE September 13, 2018: Acorda Therapeutics, Inc today announced that the U.S. Food and Drug Administration (FDA) has extended its decision date on inhaled levodopa to January 5, 2019 (Feb 20 2018).
eds195 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
johnt (10-12-2018)
Old 10-11-2018, 12:09 PM #5
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
Default

i worry about inhaled drugs in general, especially a powder. but i think the expected high price for inhaled C/L will limit it to emergencies so noone is going to replace oral C/L with inhaled. it's too bad it's taking so long to bring it to market. keep in mind that the sublingual apomorphine also goes directly into your blood and sounds like it gets there quicker than inhaled C/L and in a much easier to use and likely safer mode of delivery for those with respiratory difficulties. can't really compare apples to apples with these 2 drugs and there is the issue of how tolerable is low dose apomorphine, you can't really know until it gets out into the general public imho, injectable or continuous delivery apomorphine takes some getting used to under a dr's supervision.

Last edited by soccertese; 10-12-2018 at 09:39 AM.
soccertese is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
eds195 (10-11-2018), johnt (10-12-2018)
Old 10-12-2018, 02:49 AM #6
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
Default

In order to better understand the effect of apomorphine used as a rescue drug, I think it is worth drawing graphs of levodopa equivalent plasma levels over the course of a day, with and without a dose of apomorphine, and with and without a dose delayed due to, for instance, eating protein.

I have written an app to do that. See:

Parkinson's Disease Measurement: PwP, surveys, trials, analysis

All the references to the literature are there.

(You can use this tool yourself. Just go to the web page, input details of your drug regimen and the program will draw the graph for you.)

Note that the pharmacokinetic parameters used are from a intra nasal version of apomorphine, and not from the sub-lingual version, Sunovion, but I wouldn't expect them to be greatly different.

In all the scenarios below the "on" threshold is set at 50 LED mg. This figure will vary greatly from person to person.

In the graphs below, the coloured lines show the contribution made by each of the doses. The black line shows the total at each time. The horizontal green line at 50 is the assumed "on" threshold.

Scenario 1. Five doses of 100mg levodopa/carbidopa taken at 0700, 1000, 1300, 1600 and 1900.

Plasma max (LED mg) = 127
On duration (min) = 760
Off duration (min) = 680

original.png

***************************

Scenario 2. Five doses of 100mg levodopa/carbidopa taken at 0700, 1000, 1300, 1600 and 1900. But, due to, for instance, protein in the diet, the 1300 dose's action is delayed by 60 minutes and, then, only delivers 70% of the normal amount of levodopa.

Plasma max (LED mg) = 131
On duration (min) = 700
Off duration (min) = 740

delayedDose.png

***************************

Scenario 3. As scenario 2, but additionally a 10mg dose of apomorphine is taken at 1400, because there is an unexpected "off".

Plasma max (LED mg) = 244
On duration (min) = 723
Off duration (min) = 717

apomorphine.png

***************************

Obviously the answer will vary from person to person, but the question that this raises is:

Is the extra 23 minutes of "on" time worth the near doubling of levodopa equivalent peak plasma levels, and the effect that this may have on dyskinesia?

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
eds195 (10-12-2018)
Old 10-12-2018, 10:10 AM #7
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
Default

johnt, bottom line, when your're OFF the measurement that is most important is how much L-DOPA is crossing the BBB, not how much is in the blood. The fact that you are OFF tells you that it's not enough. You've eaten more than enough protein to overwhelm the active transport system that moves the L-DOPA and all other similar amino acids across the BBB. It's pretty clear that 15grams of protein is 100x the amount of amino acids that is in 150mg of C/L - admittedly not all AA's in protein use the same transport system that moves L-DOPA across the BBB but it's enough AA's to prevent much L-DOPA from crossing the BBB, so i guess it take 2hrs for your body to move the AA's out of your blood into cells? so instead of getting into the brain, l-dopa is blocked from crossing the BBB and as it circulates thru the body more and more of it is destroyed so none gets into the brain. so i have to assume apomorphine uses a different transport system into the brain than l-dopa uses otherwise it isn't going to help when you eat too much protein. my point is that you can have a very high L-DOPA blood concentration and be OFF, in the real world you have to also measure total AA's. of course eating protein only becomes a major problem when you are advanced enough that you are producing very little of your own brain dopamine, i.e., past the 5 year "honeymoon" phase. isn't it just slightly amazing that after 40 or more years since c/l came on the market we are still discussing such basic problems? there should have been a "cure" by now.
soccertese is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
eds195 (10-12-2018)
Old 10-14-2018, 04:16 AM #8
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
Default

Judging by the questions that soccertese quite rightly asks, I think that I gave too little explanation of what was going on in Scenario 3. I'm assuming that:
- the person has taken 100mg doses of levodopa at 0700 and 1000 and these have worked;
- at 1300 the person goes into an expected "off" as the previous dose (1000) wears off as normal;
- at 1300 the person unknowingly eats a substantial amount of protein, which delays for 1 hour any passing of levodopa into the brain, and ultimately reduces the bioavailability by 30%;
- this is modelled by replacing the 1300 dose with one at 1400, with only 70% of the dose;
- the patient will have to make a decision as to what to do as he doesn't feel the 1300 dose kicking in, I'm assuming that he will give this one hour's grace before writing it off as a lost dose, he then takes the rescue dose;
- this is modelled as an 10mg apomorphine dose at 1400.

It is important not to take Scenario 3 as the only possible case. There are many other scenarios to explore: what if the rescue dose is taken at 1330?; what if the 1300 dose is completely lost?

It is of the nature of mathematical models that they only show part of reality, but not all of it. What I've developed here is a pharmacokinetic (what the body does to the drug) model, when what we are really interested in are the pharmacodynamics (what the drug does to the body) of the situation.

soccertese writes:

'isn't it just slightly amazing that after 40 or more years since c/l came on the market we are still discussing such basic problems? there should have been a "cure" by now.'

I completely agree. I'm now 13 years post diagnosis, and so I'm unlikely to benefit from any new drugs. But what I can do is to get more out of existing drugs. I think that mathematical models have a part to play in that process.

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
soccertese (10-14-2018)
Old 10-14-2018, 06:05 PM #9
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
Default

injectable apo has been accepted as a pd drug maybe even longer than l-dopa so i think a benefit analysis has been done for the sublingual so i'm assuming the mfg has laid out the most common situations where a patient would benefit by being able to go ON faster, even if it's just 20minutes. forget the food, there are times when i need to get ON 20 min. faster, this could be when i'm away from home and going OFF would ruin a good time. someone still working could greatly benefit. i agree having a better planned drug regime is the better choice but there are days when i barely come ON due to constipation or some other mysterious cause where i need that rescue drug, C/L just ain't working. if i have to get up at night because my house is on fire i'm going to grab that rescue drug to get on ASAP, even if it's only 20minutes sooner.
soccertese is offline   Reply With QuoteReply With Quote
Reply

Tags
awaits, decision, episodes, fda, treat

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off



All times are GMT -5. The time now is 12:06 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.